Cynata Therapeutics Limited

ASX:CYP ISIN:AU000000CYP7

 
 

News

Regeneus Ltd (ASX:RGS) Appoints International Directors for Global Growth

🕔4/29/2019 8:48:54 AM 4711

Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, is pleased to announce the appointment of John Chiplin, PhD and Alan W. Dunton, M.D. to its Board of Directors, effective 29 April 2019 as independent, Non-Executive Directors.

Read Full Article

Chapmans Limited (ASX:CHP) to Make Strategic Medicinal Cannabis Sector Investment

🕔8/29/2017 12:35:47 PM 8668

The Directors of Chapmans Limited (ASX:CHP) are pleased to announce that the Company has entered into a Binding Heads of Agreement with MJ Life Sciences Pty Ltd, to make a strategic investment of US$500,000 in MJLS.

Read Full Article
###

4,326 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 7) (Last 30 Days: 27) (Since Published: 4326) 

Company Data

More News Results

  • 2024/03/20: EU Approval for Phase 2 CYP-001 Trial in GvHD*
  • 2024/03/18: Cynata Presenting at Advanced Therapies Congress*
  • 2024/03/05: First Patient Treated in Phase 2 GvHD Trial*
  • 2024/02/29: Cynata Appoints New Chief Business Officer*
  • 2024/02/26: Encouraging Initial Data from CYP-006TK DFU Trial*
  • 2024/02/23: Appendix 4D & Half-Year Financial Statements*
*refer to company website